MedTrace Logo

Ketamine Versus Dexmedetomidine With Local Anesthetic in TAP Block

NCT03060070 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2017-07-05

No results posted yet for this study

Summary

Comparing the analgesic effects of ketamine and dexmedetomidine when added to local anesthetic in TAP block for postoperative analgesia after lower abdominal cancer surgery.

Conditions

  • Postoperative Analgesia
  • Lower Abdominal Cancer

Interventions

DRUG

Ketamine

Ketamine at a dose of 0.5mg/kg will be added to bupivacaine 0.25 (total volume 20ml) in each side using sonar guided TAP block

DRUG

dexmedetomidine

dexmedetomidine at a dose of 1ug/kg will be added to bupivacaine 0.25 (total volume 20ml) in each side using sonar guided TAP block

DRUG

control group

20ml of 0.25% bupivacaine will be injected in each side of the TAP block

Sponsors & Collaborators

  • South Egypt Cancer Institute

    collaborator OTHER

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-10
Primary Completion
2017-06-25
Completion
2017-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03060070 on ClinicalTrials.gov